Accordingly, we have reported for the first-time specific MoA that RUNX1 could play a role in NAFLD pathogenesis motives, but this is only an in silico study and needs to be further validated in experimental research. The gene discussed is RUNX1; the disease is metabolic dysfunction-associated steatotic liver disease.